John A. Glaspy
Chair of Its Management Committee · Stand Up to Cancer
Credentials: · · · · · ·
History
- Present
Jonsson Comprehensive Cancer Center (JCCC) of the University of California, Los Angeles (UCLA) School of Medicine
- Present
University of California, Los Angeles (UCLA) School of Medicine
Until 1985- Until 1983
- Until 1980
Research
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Nature · 2014 · 5,545 citations
Adjuvant trastuzumab in HER2-positive breast cancer
New England Journal of Medicine · 2011 · 2,131 citations
Journal of Clinical Oncology · 1998 · 903 citations
50 papers
39 papers
- CH
18 papers · 4 as a resident
17 papers
14 papers
- RH
14 papers
11 papers
11 papers
Grants
- 1996–2030
National Cancer Institute · P30
Project lead · $2.9M · University of California Los Angeles
- 2009–2015
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
National Cancer Institute · U54
Project lead · $636.8K · University of California Los Angeles
- 1997–2002
Signal Transduction in Oncogenesis
National Cancer Institute · P01
Project lead · $525.7K · University of California Los Angeles
- 1997–2001
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $454.3K · University of California Los Angeles
Clinical trials
- 2021–2028
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Principal investigator · Recruiting · Phase 2
Jonsson Comprehensive Cancer Center
- 2019–2023
Principal investigator · Terminated · Phase 1
Jonsson Comprehensive Cancer Center
- 2018–2020
Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Principal investigator · Completed · Phase 3
EVIVE Biotechnology
- 2009–2019
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center